157 related articles for article (PubMed ID: 21152924)
21. [Does PCA3 score and prostatic MRI help selection of patients scheduled for initial prostatic biopsy?].
Vinet M; Vlaeminck-Guillem V; Rouvière O; Perrin P; Paparel P; Devonec M; Adam E; Briant PE; Ruffion A
Prog Urol; 2013 Feb; 23(2):121-7. PubMed ID: 23352305
[TBL] [Abstract][Full Text] [Related]
22. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.
Stephan C; Jung M; Rabenhorst S; Kilic E; Jung K
Clin Chem Lab Med; 2015 Jun; 53(7):1109-18. PubMed ID: 25720086
[TBL] [Abstract][Full Text] [Related]
23. The role of urine prostate cancer antigen 3 mRNA levels in the diagnosis of prostate cancer among Hong Kong Chinese patients.
Ng CF; Yeung R; Chiu PK; Lam NY; Chow J; Chan B
Hong Kong Med J; 2012 Dec; 18(6):459-65. PubMed ID: 23223645
[TBL] [Abstract][Full Text] [Related]
24. Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer.
Wu AK; Reese AC; Cooperberg MR; Sadetsky N; Shinohara K
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):100-5. PubMed ID: 22042252
[TBL] [Abstract][Full Text] [Related]
25. A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result.
Donovan MJ; Noerholm M; Bentink S; Belzer S; Skog J; O'Neill V; Cochran JS; Brown GA
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):370-5. PubMed ID: 26345389
[TBL] [Abstract][Full Text] [Related]
26. A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy.
Sokoll LJ; Ellis W; Lange P; Noteboom J; Elliott DJ; Deras IL; Blase A; Koo S; Sarno M; Rittenhouse H; Groskopf J; Vessella RL
Clin Chim Acta; 2008 Mar; 389(1-2):1-6. PubMed ID: 18061575
[TBL] [Abstract][Full Text] [Related]
27. Prostate cancer detection rate at repeat saturation biopsy: PCPT risk calculator versus PCA3 score versus case-finding protocol.
Pepe P; Aragona F
Can J Urol; 2013 Feb; 20(1):6620-4. PubMed ID: 23433132
[TBL] [Abstract][Full Text] [Related]
28. Histological chronic prostatitis and high-grade prostate intra-epithelial neoplasia do not influence urinary prostate cancer gene 3 score.
De Luca S; Passera R; Milillo A; Coda R; Randone DF
BJU Int; 2012 Dec; 110(11 Pt B):E778-82. PubMed ID: 23116408
[TBL] [Abstract][Full Text] [Related]
29. Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results.
van Gils MP; Hessels D; Hulsbergen-van de Kaa CA; Witjes JA; Jansen CF; Mulders PF; Rittenhouse HG; Schalken JA
Prostate; 2008 Aug; 68(11):1215-22. PubMed ID: 18500693
[TBL] [Abstract][Full Text] [Related]
30. PCA3 urine mRNA testing for prostate carcinoma: patterns of use by community urologists and assay performance in reference laboratory setting.
Shappell SB; Fulmer J; Arguello D; Wright BS; Oppenheimer JR; Putzi MJ
Urology; 2009 Feb; 73(2):363-8. PubMed ID: 18995890
[TBL] [Abstract][Full Text] [Related]
31. Controversies in using urine samples for Prostate Cancer detection: PSA and PCA3 expression analysis.
Fontenete S; Silva J; Teixeira AL; Ribeiro R; Bastos E; Pina F; Medeiros R
Int Braz J Urol; 2011; 37(6):719-26. PubMed ID: 22234006
[TBL] [Abstract][Full Text] [Related]
32. Rational approach to implementation of prostate cancer antigen 3 into clinical care.
Wang R; Chinnaiyan AM; Dunn RL; Wojno KJ; Wei JT
Cancer; 2009 Sep; 115(17):3879-86. PubMed ID: 19517474
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide association study identifies genetic determinants of urine PCA3 levels in men.
Chen Z; Sun J; Kim ST; Groskopf J; Feng J; Isaacs WB; Rittmaster RS; Condreay LD; Zheng SL; Xu J
Neoplasia; 2013 Apr; 15(4):448-53. PubMed ID: 23555189
[TBL] [Abstract][Full Text] [Related]
34. PCA3 as a second-line biomarker in a prospective controlled randomized opportunistic prostate cancer screening programme.
Rubio-Briones J; Casanova J; Martínez F; Domínguez-Escrig JL; Fernández-Serra A; Dumont R; Ramírez-Backhaus M; Gómez-Ferrer A; Collado A; Rubio L; Molina A; Vanaclocha M; Sala D; Lopez-Guerrero JA
Actas Urol Esp; 2017 Jun; 41(5):300-308. PubMed ID: 28342633
[TBL] [Abstract][Full Text] [Related]
35. A duplex quantitative polymerase chain reaction assay based on quantification of alpha-methylacyl-CoA racemase transcripts and prostate cancer antigen 3 in urine sediments improved diagnostic accuracy for prostate cancer.
Ouyang B; Bracken B; Burke B; Chung E; Liang J; Ho SM
J Urol; 2009 Jun; 181(6):2508-13; discussion 2513-4. PubMed ID: 19371911
[TBL] [Abstract][Full Text] [Related]
36. Age-Adapted Prostate Cancer Gene 3 Score Interpretation - Suggestions for Clinical Use.
Hennenlotter J; Neumann T; Alperowitz S; Wagner V; Hohneder A; Bedke J; Stenzl A; Todenhöfer T; Rausch S
Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162868
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes.
Hendriks RJ; Dijkstra S; Jannink SA; Steffens MG; van Oort IM; Mulders PF; Schalken JA
Clin Chem Lab Med; 2016 Mar; 54(3):483-92. PubMed ID: 26630694
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance.
Tosoian JJ; Patel HD; Mamawala M; Landis P; Wolf S; Elliott DJ; Epstein JI; Carter HB; Ross AE; Sokoll LJ; Pavlovich CP
Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):339-342. PubMed ID: 28417979
[TBL] [Abstract][Full Text] [Related]
39. Reflex PCA3 messenger ribonucleic acid testing: validation of postbiopsy urine samples and correlation with prostate biopsy findings in ∼2000 patients.
Brown JG; Fulmer JR; Romano J; Pownell J; Rigler W; Wirtshafter A; Sarno M; Shappell SB
Urology; 2014 Nov; 84(5):1172-80. PubMed ID: 25443926
[TBL] [Abstract][Full Text] [Related]
40. Urinary PCA3 score predicts prostate cancer multifocality.
Vlaeminck-Guillem V; Devonec M; Colombel M; Rodriguez-Lafrasse C; Decaussin-Petrucci M; Ruffion A
J Urol; 2011 Apr; 185(4):1234-9. PubMed ID: 21334023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
